Content area
Abstract
By not adhering to AYUSH-64 alone as originally decided, the entire objective of scientific exercise becomes flawed, and inferences therefrom equivocal. Because allopathic drugs were co-administered without an appropriate modification in the methodology capable of discerning the comparative effect, there is no way one can find out the proportionate effect of AYUSH-64 in the intervened condition. For most individuals, Influenza like illness is usually self-limiting with symptoms lasting for about 5–7 days. [...]in ILI, only symptomatic management is necessary and not the antiviral therapy [ 6]. None of these conditions apply to participants in the study because of their stated inclusion criteria. Since the period of follow-up in the study matched with the period of potentially spontaneous recovery, the interpretation that AYUSH-64 intervention was effective becomes erroneous. A clinical trial has already been proposed on this drug against COVID-19. [...]scientific community now conducting research on AYUSH-64 should exercise extra caution in light of the previous uneasy experiences with this drug.
Details
